Insomnia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Increasing Prevalence of Insomnia Sparks Growth in Treatment Market, Offering Opportunities for Pharmaceutical Companies

Insomnia, a pervasive and debilitating condition affecting millions worldwide, continues to escalate as a pressing public health concern. Despite the availability of effective treatment options, approximately 25% of the adult population grapples with sleeping disorders, with 6-10% diagnosed specifically with insomnia. In response to this growing crisis, the global insomnia treatment market is poised for substantial expansion during the forecast period of 2024-2031.

OTC Medications and Innovations Drive Market Growth

The rising demand for Over-The-Counter (OTC) sleep aids, coupled with the aging population – with a projected 56% increase in those aged 60 and above by 2030 – underscores the urgency for accessible and effective insomnia therapeutics. OTC drugs, such as natrol melatonin and unisom sleep gel, are anticipated to dominate the market, representing a significant share of revenue through 2031. Moreover, ongoing research efforts by leading pharmaceutical companies focus on developing novel pharmacological treatments, exploring diverse categories including neurokinin1 receptor antagonists, 5-HT1A agonists, and corticotropin-releasing hormone antagonists.

Cognitive Behavioral Therapy and Emerging Markets Offer Promising Opportunities

In addition to pharmacological interventions, cognitive behavioral therapy for insomnia (CBT-I) emerges as a highly effective treatment modality, particularly for older adults. Furthermore, developing economies like China and India present lucrative markets for healthcare facilities and sleep aids, with substantial opportunities for expansion and market penetration. The presence of a sizable undiagnosed insomnia patient pool underscores the imperative for improved recognition, diagnosis, and treatment strategies.

Unlocking Opportunities in the Sleep-Health Economy

The burgeoning multi-billion dollar sleep-health economy reflects the escalating demand for sound sleep solutions. This trend not only offers lucrative market opportunities for pharmaceutical companies but also creates avenues for retailers, health service providers, and consumer-oriented businesses to contribute to addressing the global insomnia epidemic.

Competitive Analysis

Key players in the insomnia treatment market include:

• Sunovion Pharmaceuticals, Inc.
• Natrol, LLC
• GlaxoSmithKline Plc.
• Sanofi SA
• Pfizer Inc.
• Boehringer Ingelheim International GmbH
• Mallinckrodt
• PERNIX Therapeutics
• Takeda Pharmaceutical Company Limited
• Merck & Co. Inc.
• Others.

Market Segmentation

By Drug Type

• OTC Drugs
• OTC Sleep Aids
• OTC Sleep Supplements
• Prescription Drugs

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• e commerce
• Drug Stores
• Others

By Region

• North America
• Latin America
• Europe
• Asia Pacific Excluding China
• China
• Middle East & Africa

This product will be delivered within 1-3 business days.